## The major NIMH trail that proved the superiority of stimulants for treating ADHD over therapy did not include a placebo group and 20 percent of the therapy group were on stimulants # 

The [[NIMH]] touted its [[ADHD]] study as â€œthe first major clinical trialâ€ the institute had ever conducted of â€œa childhood [[mental disorder]].â€ However, it was a rather flawed intellectual exercise right from the start. Although the investigators, led by [[Peter Jensen]], associate director of child and adolescent research at the [[NIMH]], acknowledged during the planning stages that there was no evidence in the scientific literature that [[stimulant]]s improved long-term outcomes ([[Stimulants have been shown to not improve behavior over the long-term]]), they did not include a placebo control in the study, reasoning that it would have been â€œunethicalâ€ to withhold â€œtreatment of known efficacyâ€ for an extended period. The study basically compared drug treatment to behavioral therapy, but in that latter group, 20 percent were on a [[stimulant]] at the start of the trial, and there never was a time during the fourteen months that all of the children in that group were off such medication.

Despite this obvious design flaw, the [[NIMH]]-funded investigators declared victory for the [[stimulant]]s at the end of fourteen months. â€œCarefully crafted medication managementâ€ had proven to be â€œsuperiorâ€ to behavioral treatment in terms of reducing core [[ADHD]] symptoms. There was also a hint that the medicated children had fared better on reading tests (although not in other academic subjects), and as a result, psychiatry now had a long-term study that documented the continuing benefits of stimulants. â€œSince [[ADHD]] is now regarded by most experts as a chronic disorder, ongoing treatment often seems necessary,â€ the researchers concluded.

___

##### References

- Whitaker, Robert. (2010). [[Anatomy of an Epidemic Chapter 11 The Epidemic Spreads to Children]] (Epub p. 309). New York , NY: _Crown Publishing_.

##### Metadata

Type: #ğŸ”´ 
Tags: [[Psychiatry]] / [[Pharmacology]]
Status: #â˜€ï¸ 